Coenzyme Q10 and congestive heart failure: What is the verdict?

Canadian Journal of Cardiology

Volumn 18, Issue 10, 2002, Pages 1054-1058

  Raj, Satish R ^b   Weisel, Richard D ^a   Verma, Subodh ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PLACEBO; UBIDECARENONE; VASODILATOR AGENT;

CLINICAL STUDY; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DISEASE SEVERITY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; EXERCISE TOLERANCE; FATALITY; GASTROINTESTINAL SYMPTOM; HEART FUNCTION; HEART HEMODYNAMICS; HEMODYNAMIC MONITORING; HOSPITALIZATION; HUMAN; LONG TERM CARE; MEDICAL ASSESSMENT; MORTALITY; NONHUMAN; REVIEW; SHORT COURSE THERAPY; SIDE EFFECT; SUPPLEMENTATION; TREATMENT PLANNING;

ANIMALS; CRICETINAE; DISEASE MODELS, ANIMAL; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HEART FUNCTION TESTS; HEMODYNAMIC PROCESSES; HUMANS; MALE; RANDOMIZED CONTROLLED TRIALS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UBIQUINONE;

EID: 0036815180     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Yamamura Y. A survey of the therapeutic uses of coenzyme Q10. In: Lenaz G, ed. Coenzyme Q Biochemistry, Bioenergetics, and Clinical Applications of Ubiquinone. New York: Wiley-Interscience, 1985:479-507.
2. Folkers K, Littani G, Ho L, Runge TM, Havanenda S, Colley D. Evidence for a deficiency of coenzyme Q10 in human heart disease. Int J Vit Nutr Res 1970;40:380-90.
3. Mortensen SA. Endomyocardial biopsy: Technical aspects and indications. Dan Med Bull 1989;36:507-32.
4. Mortensen SA, Kondrup J, Folkers K. Myocardial deficiency of coenzyme Q10 and carnitine in cardiomyopathy. Biochemical rationale for concomitant coenzyme Q10 and carnitine supplementation. In: Folkers K, Littarru GP, Yamagami T, eds. Biomedical and Clinical Aspects of Coenzyme Q. Amsterdam: Elsevier, 1991:269-81.
5. Momomura SI, Yamashita H, Ohtani Y, Serizawa T, Iizuka M, Sugimoto T. Coenzyme Q10 attenuates progression of cardiac disease process in cardiomyopathic hamsters. In: Folkers K, Littarru GP, Yamagami T, eds. Biomedical and Clinical Aspects of Coenzyme Q. Amsterdam: Elsevier, 1991:233-40.
6. Judy WV, Hall JH, Toth PD, Folkers K. Myocardial effects of coenzyme Q10 in primary heart failure, in Folkers K, Yamamura Y, eds. Biomedical and Clinical Aspects of Coenzyme Q. Amsterdam: Elsevier, 1984:353-67.
7. Lampertico M, Comis S. Italian multicenter study on the efficacy and safety of coenzyme Q10 as adjuvent therapy in heart failure. Clin Invest 1993;71:S129-33.
8. Langsjoen PH, Folkers K. Long-term efficacy and safety of coenzyme Q10 therapy for idiopathic dilated cardiomyopathy. Am J Cardiol 1990;65:521-3.
9. Judy WV, Hall JH, Folkers K. Coenzyme Q10 withdrawal - Clinical relapse in congestive heart failure patients. In: Folkers K, Littarru GP, Yamagami T, eds. Biomedical and Clinical Aspects of Coenzyme Q. Amsterdam: Elsevier, 1991:283-90.
10. Di Somma S, Carati L. Efficacy of coenzyme Q in association with conventional therapy in the treatment of heart failure and ischemic heart disease. In: Folkers K, Littarru GP, Yamagami T, eds. Biomedical and Clinical Aspects of Coenzyme Q. Amsterdam: Elsevier, 1991:257-65.
11. Judy WV, Folkers K, Hall JH. Improved long-term survival in coenzyme Q10-treated congestive heart failure patients compared to conventionally treated patients. In: Folkers K, Littarru GP, Yamagami T, eds. Biomedical and Clinical Aspects of Coenzyme Q. Amsterdam: Elsevier, 1991:291-8.
12. Langsjoen PH, Vadhanavikit S, Folkers K. Response of patients in classes III and IV of cardiomyopathy to therapy in a blind and crossover trial with coenzyme Q10. Proc Nat Acad Sci USA 1985;82:4240-4.
13. Judy WV, Hall JH, Toth PD, Folkers K. Double blind crossover study of coenzyme Q10 in heart failure. In: Folkers K, Yamamura Y, eds. Biomedical and Clinical Aspects of Coenzyme Q. Amsterdam: Elsevier, 1986:315-23.
14. Rossi E, Lombardo A, Testa M, et al. Coenzyme Q10 in ischemic cardiomyopathy. In: Folkers K, Littarru GP, Yamagami T, eds. Biomedical and Clinical Aspects of Coenzyme Q. Amsterdam: Elsevier, 1991:321-6.
15. Mazzola C, Guffanti EE, Vaccarella A, et al. Noninvasive assessment of coenzyme Q10 in patients with chronic stable effort angina and moderate heart failure. Curr Ther Res 1987;41:923-32.
16. Poggesi L, Galanti G, Comeglio M, Toncelli L, Vinvi M. Effects of coenzyme Q10 on left ventricular function in patients with dilative cardiomyopathy: A medium-term randomized double-blind study versus placebo. Curr Ther Res 1991;49:878-86.
17. Morisco C, Nappi A, Argenziano L, et al. Noninvasive evaluation of cardiac hemodynamics during exercise in patients with chronic heart failure: Effects of short-term coenzyme Q10 treatment. Mol Aspects Med 1994;15:S155-63.
18. Morisco C, Trimarco B, Condorelli M. Effects of coenzyme Q10 therapy in patients with congestive heart failure: A long-term multicenter randomized study. Clin Invest 1993;71:S136.
19. Hofman-Bang C, Rehnqvist N, Swedberg K, Wiklund I, Astrom H. Coenzyme Q10 as an adjunctive in the treatment of chronic congestive heart failure. J Card Fail 1995;1:101-7.
20. Permanetter B, Rossy W, Klein G, Weingartner F, Seidl KF, Blomer H. Ubiquinone (coenzyme Q10) in the long-term treatment of idiopathic dilated cardiomyopathy. Eur Heart J 1992;13:1528-33.
21. Watson PS, Scalia GM, Galbraith A, Burstow DJ, Bett N, Aroney CN. Lack of effect of coenzyme Q on left ventricular function in patients with congestive heart failure. J Am Coll Cardiol 1999;33:1549-52.
22. Khatta M, Alexander BS, Krichten CM, et al. The effects of coenzyme Q10 in patients with congestive heart failure. Ann Int Med 2000;132:636-40.